| Plasma Cell Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived193 of 193show fewer |
|---|
| → investigated in trials for | Dexamethasonesmall_molecule 689 trials (216 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 689 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall_molecule 389 trials (137 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 389 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 375 trials (90 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 375 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall_molecule 227 trials (49 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 227 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 207 trials (113 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 207 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 185 trials (77 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 185 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall_molecule 174 trials (23 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 174 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 166 trials (68 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 166 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 154 trials (28 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 154 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall_molecule 80 trials (5 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 71 trials (11 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belantamab Mafodotinadc 58 trials (38 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elotuzumabmonoclonal antibody 57 trials (18 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Isatuximabmonoclonal antibody 56 trials (44 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 50 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teclistamabmonoclonal antibody 45 trials (41 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elranatamabmonoclonal antibody 44 trials (35 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 43 trials (23 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 41 trials (4 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall_molecule 34 trials (3 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talquetamabmonoclonal antibody 32 trials (27 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 31 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 31 trials (3 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 29 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 29 trials (7 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 26 trials (4 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 26 trials (10 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 23 trials (3 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall_molecule 22 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall_molecule 20 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linvoseltamabmonoclonal antibody 16 trials (14 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idecabtagene Vicleucelgene_therapy 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nirogacestatsmall molecule 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall_molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ciltacabtagene Autoleucelgene therapy 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall_molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 6 trials (6 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalan Flufenamidesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall_molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic Cell Transplantation 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Masitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Meloxicamsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pasireotideother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ridaforolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amrubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bone Marrow Transplantation 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenib/Trametinib Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Degarelixother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gilteritinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibandronic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Luminespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mcl-1 Inhibitor MIK665 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirdametinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | MUC1-targeted Peptide GO-203-2C 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onatasertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PCV Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retaspimycin Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Uprosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |